Matthew D. Davis, MD

Dr. Davis is Professor Emeritus of Ophthalmology and Vision Science at the University of Wisconsin-Madison. He is widely recognized as an expert in the interpretation of clinical fundus images (including fluorescein and indocyanine green angiography). He is also the founder of the Fundus Photograph Reading Center, Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison; an international resource for fundus interpretation.

To learn more about Dr. Davis' research, please click here:

Recent Publications


Related Articles

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.

Mov Disord. 2016 Mar 31;

Authors: Weintraub D, Hauser RA, Elm JJ, Pagan F, Davis MD, Choudhry A, MODERATO Investigators


Related Articles

Maintenance of Nucleosomal Balance in cis by Conserved AAA-ATPase Yta7.

Genetics. 2014 Nov 17;

Authors: Lombardi LM, Davis MD, Rine J

Related Articles

The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes: The Action to Control Cardiovascular Risk in Diabetes Eye Study.

Ophthalmology. 2014 Aug 26;

Authors: Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT, Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group

Related Articles

Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36.

JAMA Ophthalmol. 2014 Jan 2;

Authors: Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL, for the Age-Related Eye Disease Study Research Group


Related Articles

Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35.

Ophthalmology. 2013 Apr 10;

Authors: Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD, Age-Related Eye Disease Study Research Group

Related Articles

Randomized controlled effectiveness trial of reciprocal peer support in heart failure.

Circ Heart Fail. 2013 Mar 1;6(2):246-53

Authors: Heisler M, Halasyamani L, Cowen ME, Davis MD, Resnicow K, Strawderman RL, Choi H, Mase R, Piette JD

Related Articles


Retina. 2013 July/August;33(7):1393-1399

Authors: Gangaputra S, Lovato JF, Hubbard L, Davis MD, Esser BA, Ambrosius WT, Chew EY, Greven C, Perdue LH, Wong WT, Condren A, Wilkinson CP, Agrón E, Adler S, Danis RP, for the ACCORD Eye Research

Related Articles

The Effect of the Oral PKC β Inhibitor Ruboxistaurin on Vision Loss in Two Phase 3 Studies.

Invest Ophthalmol Vis Sci. 2013;54(3):1750-7

Authors: Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH, MBDL and MBCU Study Groups


Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.

Retina. 2011 Nov;31(10):2084-94

Authors: Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC,

Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus.

Invest Ophthalmol Vis Sci. 2011 Aug;52(9):6168-73

Authors: Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD,

Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Arch Ophthalmol. 2011 Jun;129(6):718-26

Authors: Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD,

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).

Retina. 2011 Jun;31(6):1053-9

Authors: Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP,

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

Arch Intern Med. 2011 Mar 14;171(5):412-20

Authors: de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, , White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM


Effects of medical therapies on retinopathy progression in type 2 diabetes.

N Engl J Med. 2010 Jul 15;363(3):233-44

Authors: , , Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ

Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema.

Ophthalmology. 2010 May;117(5):946-53

Authors: Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, Ferris F, Glassman AR, Ip MS, Miller KM,

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

Diabetes. 2010 May;59(5):1244-53

Authors: White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD,